New diabetes clinical trial: Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Published on: 2026-09-18T04:00:00Z Conditions : Chronic Limb-Threatening Ischemia; Diabetic Foot Ulcer; Infrapopliteal Arterial Occlusive Disease Interventions : Procedure: Lower-Extremity Revascularization; Genetic: Donaperminogene Seltoplasmid Sponsors : First Affiliated Hospital of Wenzhou Medical University; Beijing Northland Biotech. Co., Ltd. Not yet recruiting https://ift.tt/cJMeNCO